News & Blog (Demo)

23 Mar13:57
23 Mar13:57
Mar 2021
Mar 2021
Innate Killer Summit 2021

Vycellix to Present at Upcoming Life Science Conferences

Vycellix, Inc., an immuno-centric discovery life science company with a focus on natural killer cell-based (NK cell) therapeutics, today announced that members of its executive leadership team are scheduled to present and moderate panel sessions at the following upcoming life science conferences this week.
24 Mar12:36
24 Mar12:36
Mar 2020
Mar 2020
shutterstock_591898883-LR

Vycellix and Avectas Announce Collaboration to Advance Next-Generation Solutions for the Optimized Manufacture of Cell & Gene Therapies

TAMPA, FLORIDA & DUBLIN, IRELAND – March 25, 2020 – Vycellix™, Inc., an immuno-discovery cell & gene therapy company, and Avectas Limited, a cell engineering technology business, today jointly announced that the companies have entered into a collaboration agreement to develop proprietary approaches for cell-based immunotherapeutic products.